首页 | 本学科首页   官方微博 | 高级检索  
检索        

我国药品价格管制政策失灵的成因分析及对策探讨
引用本文:王志强,卢祖洵,胡大琴,金新政.我国药品价格管制政策失灵的成因分析及对策探讨[J].中国药房,2008,19(22):1681-1683.
作者姓名:王志强  卢祖洵  胡大琴  金新政
作者单位:华中科技大学同济医学院公共卫生学院,武汉市,430030
摘    要:目的:为强化我国药品价格管制效果和推进相关体制改革提供思路。方法:运用经济学理论和比较分析的方法对我国药品价格管制政策失灵的成因及对策进行分析。结果与结论:医药领域的信息不对称、医疗机构处于特殊垄断地位、被管制者规避管制等是导致价格管制失灵的原因,解决这一问题,需要进行多方面的改革,提高价格管制的科学性,改善管制政策的传导机制。

关 键 词:价格管制  政策失灵  信息不对称  管制俘获

Failure of Drug Price Control Policy in China: Causes and Countermeasures
WANG Zhi qiang,LU Zu-xun,HU Da-qin,JIN Xin-zheng.Failure of Drug Price Control Policy in China: Causes and Countermeasures[J].China Pharmacy,2008,19(22):1681-1683.
Authors:WANG Zhi qiang  LU Zu-xun  HU Da-qin  JIN Xin-zheng
Institution:(School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China)
Abstract:OBJECTIVE: To discuss the ways to improve the drug control outcome in China and to facilitate the related system reform. METHODS: The causes and countermeasures for the failure of drug control policy in China were analyzed comparatively using economic theory. RESULTS & CONCLUSIONS: Information dissymmetry in the medicine area, monopoly of medical institution and their evasion of control etc all resulted in the failure of price control policy. To avoid this failure, it is necessary to take reform measures in many aspects, enhance the scientificity of price control, and improve the conduction mechanism of price control policy.
Keywords:Price control  Failure of policy  Information dissymmetry  Regulatory capture
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号